Thousands enrolled in supraflex stent registry for coronary artery disease
NCT ID NCT03443999
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This registry is tracking 10,000 patients with coronary artery disease who receive the Supraflex sirolimus-eluting stent during routine care. The goal is to see how well the stent works in everyday practice, measuring outcomes like heart-related death, heart attacks, and the need for repeat procedures. Participants will be followed for up to five years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Supraflex Family Sirolimus-eluting Coronary Stent System
- What this could lead to
- If successful, this could confirm that the Supraflex stent is safe and effective for routine use in a wide range of patients with blocked heart arteries.
- What could go wrong
- This is an observational registry, not a randomized trial, so results may be influenced by patient selection. Stent procedures carry risks like blood clots or re-narrowing of arteries.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Albert Schweitzer Ziekenhuis
RECRUITINGDordrecht, South Holland, Post bus 444 3300 AK, Netherlands
-
Amphia Ziekenhuis
RECRUITINGBreda, North Brabant, 4818 CK Breda, Netherlands
-
Catharina Ziekenhuis
RECRUITINGEindhoven, North Brabant, 5623 EJ, Netherlands
-
Maasstad Ziekenhuis
RECRUITINGRotterdam, South Holland, 3079 DZ, Netherlands
-
Medical Center Leeuwarden
RECRUITINGLeeuwarden, Provincie Friesland, 8934 AD, Netherlands
-
Tergooi Ziekenhuis
RECRUITINGBlaricum, North Holland, 1261 AN, Netherlands
-
ZorgSaam Hospital
RECRUITINGTerneuzen, Zeeuws- Vlaanderen, 4535 PA, Netherlands
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?